MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance
Authors:
- Milosz WilczynskiMWMilosz Wilczynski
- Michal KielbikMKMichal Kielbik
- Daria SenderowskaDSDaria Senderowska
- Tomasz KrawczykTKTomasz Krawczyk
- Bozena SzymanskaBSBozena Szymanska
- Magdalena KlinkMKMagdalena Klink
- Jan BieńkiewiczJBJan Bieńkiewicz
- Hanna RomanowiczHRHanna Romanowicz
- Filip FrühaufFFFilip Frühauf
- Andrzej MalinowskiAMAndrzej Malinowski
Open Access
Abstract
High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression levels have never been related to patients’ clinicopathological data in epithelial ovarian cancer. We aimed to assess miRNA-103/107 expression levels in high grade serous ovarian cancer tissues. Expression levels of both miRNAs were related to the clinicopathological features and survival. We also evaluated expression levels of miRNA-103/107 and DICER in selected ovarian cancer cell lines (A2780, A2780cis, SK-OV-3, OVCAR3). We assessed the relative expression of miRNA-103/107 (quantitative reverse transcription-polymerase chain reaction) in fifty archival formalin-fixed paraffin-embedded tissue samples of primary high grade serous ovarian cancer. Then, miRNA-103/107 and DICER expression levels were evaluated in selected ovarian cancer cell lines. Additionally, DICER, N-/E-cadherin protein levels were assessed with the use of western blot. We identified miRNA-107 up-regulation in ovarian cancer in comparison to healthy tissues (p = 0.0005). In the case of miRNA-103, we did not observe statistically significant differences between cancerous and healthy tissues (p = 0.07). We did not find any correlations between miRNA-103/107 expression levels and clinicopathological features. Kaplan–Meier survival (disease-free and overall survival) analysis revealed that both miRNAs could not be considered as prognostic factors. SK-OV-3 cancer cell lines were characterized by high expression of miRNA-103/107, relatively low expression of DICER (western-blot), and relatively high N-cadherin levels in comparison to other ovarian cancer cell lines. Clinical and prognostic significance of miRNA-103/107 was not confirmed in our study.Keywords
Funding Information
- Narodowym Centrum Nauki (2018/02/X/NZ5/02278)
This publication has 21 references indexed in Scilit:
- Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancerOncology Letters, 2013
- Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Ovarian Low-grade and High-grade Serous CarcinomaAdvances in Anatomic Pathology, 2009
- MicroRNAs and Cancer: Short RNAs Go a Long WayCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Dicer, Drosha, and Outcomes in Patients with Ovarian CancerNew England Journal of Medicine, 2008
- MicroRNAs as Oncogenes and Tumor SuppressorsNew England Journal of Medicine, 2005
- Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancerMolecular Therapy, 2004
- The functions of animal microRNAsNature, 2004